Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
Clodagh Towns, Madeleine Richer, Simona Jasaityte, Eleanor J. Stafford, Julie Joubert, Tarek Antar, Alejandro Martinez-Carrasco, View ORCID ProfileMary B. Makarious, Bradford Casey, Dan Vitale, Kristin Levine, Hampton Leonard, Caroline B. Pantazis, Laurel A. Screven, Dena G. Hernandez, Claire E. Wegel, Justin Solle, Mike A. Nalls, Cornelis Blauwendraat, Andrew B. Singleton, View ORCID ProfileManuela M. X. Tan, Hirotaka Iwaki, View ORCID ProfileHuw R. Morris, the Global Parkinson’s Genetics Program (GP2)
doi: https://doi.org/10.1101/2022.11.25.22282764
Clodagh Towns
1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK
Madeleine Richer
1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK
Simona Jasaityte
1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK
Eleanor J. Stafford
1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK
Julie Joubert
1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK
Tarek Antar
2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
Alejandro Martinez-Carrasco
1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK
Mary B. Makarious
1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK
2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
Bradford Casey
3Department of Clinical Research, Michael J. Fox Foundation for Parkinson’s Research, New York City, NY, USA
Dan Vitale
4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
5Data Tecnica International, Washington, DC, USA
Kristin Levine
4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
5Data Tecnica International, Washington, DC, USA
Hampton Leonard
2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
5Data Tecnica International, Washington, DC, USA
Caroline B. Pantazis
4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
Laurel A. Screven
4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
Dena G. Hernandez
2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
Claire E. Wegel
6Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA
Justin Solle
3Department of Clinical Research, Michael J. Fox Foundation for Parkinson’s Research, New York City, NY, USA
Mike A. Nalls
2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
5Data Tecnica International, Washington, DC, USA
Cornelis Blauwendraat
4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
7Integrative Genomics Unit, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
Andrew B. Singleton
2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
Manuela M. X. Tan
8Department of Neurology, Oslo University Hospital, Oslo, Norway
Hirotaka Iwaki
2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
5Data Tecnica International, Washington, DC, USA
Huw R. Morris
1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK
Article usage
Posted May 15, 2023.
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
Clodagh Towns, Madeleine Richer, Simona Jasaityte, Eleanor J. Stafford, Julie Joubert, Tarek Antar, Alejandro Martinez-Carrasco, Mary B. Makarious, Bradford Casey, Dan Vitale, Kristin Levine, Hampton Leonard, Caroline B. Pantazis, Laurel A. Screven, Dena G. Hernandez, Claire E. Wegel, Justin Solle, Mike A. Nalls, Cornelis Blauwendraat, Andrew B. Singleton, Manuela M. X. Tan, Hirotaka Iwaki, Huw R. Morris, the Global Parkinson’s Genetics Program (GP2)
medRxiv 2022.11.25.22282764; doi: https://doi.org/10.1101/2022.11.25.22282764
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
Clodagh Towns, Madeleine Richer, Simona Jasaityte, Eleanor J. Stafford, Julie Joubert, Tarek Antar, Alejandro Martinez-Carrasco, Mary B. Makarious, Bradford Casey, Dan Vitale, Kristin Levine, Hampton Leonard, Caroline B. Pantazis, Laurel A. Screven, Dena G. Hernandez, Claire E. Wegel, Justin Solle, Mike A. Nalls, Cornelis Blauwendraat, Andrew B. Singleton, Manuela M. X. Tan, Hirotaka Iwaki, Huw R. Morris, the Global Parkinson’s Genetics Program (GP2)
medRxiv 2022.11.25.22282764; doi: https://doi.org/10.1101/2022.11.25.22282764
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2890)
- Dermatology (248)
- Emergency Medicine (433)
- Epidemiology (12634)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4496)
- Geriatric Medicine (411)
- Health Economics (718)
- Health Informatics (2877)
- Health Policy (1060)
- Hematology (381)
- HIV/AIDS (913)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4264)
- Nursing (228)
- Nutrition (626)
- Oncology (2233)
- Ophthalmology (637)
- Orthopedics (256)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6845)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)